Review compares efficacy, safety of treatments for hidradenitis suppurativa

The efficacy and safety of currently approved and pipeline medications for moderate-to-severe hidradenitis suppurativa (HS) are compared in a systematic literature review and network meta-analysis published online July 2 in JAMA Dermatology.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup